Research

Mixed

Bariatric surgery (specifically Roux-en-Y gastric bypass and sleeve gastrectomy) significantly reduces excess body weight (average 50-70% excess weight loss) and durably improves or resolves severe obesity-related comorbidities including type 2 diabetes, hypertension, and dyslipidemia, leading to prolonged survival compared to non-surgical management.

If you have a BMI of 40 or higher, or 35 or higher with serious health issues like diabetes or high blood pressure, and you have tried other treatments without lasting success, bariatric surgery is the most effective long-term option for significant weight loss and improving those health conditions. It is not a quick fix; it requires lifelong medical supervision, nutritional supplements, and dietary changes to maintain results and prevent complications.

GoodSupportsHIGH confidence
When indicated, surgical intervention leads to significant improvements in decreasing excess weight and comorbidities that can be maintained over time. These include diabetes mellitus, dyslipidemia, liver disease, systemic hypertension, obstructive sleep apnea, and cardiovascular dysfunction. Recent prospective, nonrandomized, observational, or case-control population studies have also shown bariatric surgery to prolong survival in the severely obese.
Paul Poirier et al. · Circulation · 2011

Why this rating

Based on meta-analyses of 22,000+ patients and long-term controlled studies, though mostly observational/non-randomized.

Source

Bariatric Surgery and Cardiovascular Risk Factors

Paul Poirier et al. · Circulation · 2011

DOI 10.1161/cir.0b013e3182149099

narrative_reviewCited 334×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →